Glaxo donates 50 million doses of H1N1 virus vaccine to WHO
The international laboratory GlaxoSmithKline has promised to donate 50 million doses of pandemic H1N1 vaccine to the World Health Organization (WHO) under an agreement signed at WHO headquarters in Geneva.
The agreement was signed by WHO Director-General, Dr Margaret Chan, and the Chief Executive Officer of GlaxoSmithKline, Mr Andrew Witty.
“We welcome this very generous donation by GlaxoSmithKline, which will go to protect the health of the world's poorest people. This is a real gesture of global solidarity towards those who would not be otherwise able to have access to the vaccine,” said Dr. Margaret Chan.
“WHO will now work to see that these vaccines are distributed to those who need them”, said Dr. Margaret Chan.
GSK expects to prepare the first shipments of vaccine to the WHO by the end of November. The WHO has a list of 95 developing countries that are eligible to receive donated vaccines, and aims to secure enough vaccines to cover 10% of the population of these countries.
No comments for this story
Commenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!